Inventia Healthcare Limited has recalled 13,567 bottles of chlorthalidone tablets after the product failed dissolution specifications.
The voluntary recall covers Chlorthalidone Tablets, USP, 25 milligram, packaged in 100-tablet bottles and distributed nationwide, according to an FDA enforcement report. The affected product is batch RISA24002 and has an expiration date of April 2027.
Inventia initiated the recall Sept. 3. The FDA classified it as Class II Sept. 17. The recall remains ongoing.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
